Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 placebo-controlled study of subcutaneous tildrakizumab in moderate-to-severe chronic plaque psoriasis
2012-002255-42Phase 3Unknown
- Sponsor
- Sun Pharma
- Start
- Oct 2012
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of tildrakizumab in psoriasis, sponsored by Sun Pharma. Status: unknown.
02
Drugs
tildrakizumab
03
Conditions
psoriasis
Beyond the preview
Go deeper on 2012-002255-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002255-42.